Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects

References

• Lande K, Gjesdal K, Fønstelien E, Kjeldsen S E, Eide I. Effects of adrenaline infusion on platelet number, volume and release reaction. Thromb Haemost 1985; 54: 450–3
   PubMed Web of Science ®Google Scholar
• Lande K, Os I, Kjeldsen S E, Westhcim A, Hjermann I, Eide I, Gjesdal K. Increased platelet size and release reaction in essential hypertension. J Hypertens 1987; 5: 401–6
   PubMed Web of Science ®Google Scholar
• Lande K, Kjeldsen S E, Os I, Westheim A, Hjermann I, Eide I, Gjesdal K. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens 1988; 6: 219–25
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Gjesdal K, Eide I, Aakesson I, Amundsen R, Foss O P, Lercn P. Increased beta-thromboglobulin in essential hypertension: Interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 1983; 213: 369–73
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Lande K, Jackson M B, Westheim A, Frederichsen P, Leren P, Eide I. Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension. Thromb Haemostas 1986; 56: 120–23
   Google Scholar
• Goldberg L I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972; 24: 1–29
   PubMed Web of Science ®Google Scholar
• Braunstein K M, Kay E S, Kleinfelder J, Helen B S, Colwell J A, Eurenius K. The effects of dopamine on human platelet aggregation, in vitro. J Pharmacol Exp Ther 1977; 200: 449–57
   Google Scholar
• Kodaira H, Ishikawa M, Komoda Y, Nakajima T. Time-dependent inhibition of platelet aggregation by dopamine and 3-methoxytyramine. Important roles of their metabolites. Biochem Pharmacol 1984; 33: 435–41
   Google Scholar
• Roth J A, Rivett A J. Does sulphate conjugation contribute to the metabolic inactivation of catecholamines in humans?. Biochem Pharmacol 1982; 31: 3071–2
   Google Scholar
• Hart R F, Renkers K J, Nelson E B, Roth J A. Localization and characterization of phenol sul-fotransferase in human platelets. Life Sci 1979; 24: 125–30
   PubMed Web of Science ®Google Scholar
• Da Prada M, Picotti G B. Content and subcellular localization of catecholamines and 5-hydroxy-tryptamine in human and animal blood platelets: monoamine distribution between platelets and plasma. Br J Pharmac 1979; 65: 653–62
   PubMed Web of Science ®Google Scholar
• Toth L A, Scott M C, Elchisaka M A. Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Life Sci 1986; 39: 519–26
   Google Scholar
• Romain Y, Demassieux S, D'Angelo G, Gyger M, Carriere S. Is the platelet phenosulfotrans-ferase involved in the sulfoconj ligation of plasma catecholamines?. Can J Physiol Pharmacol 1986; 64: 1197–201
   Google Scholar
• Hassan M N, Reches A, Kuhn C, Higgins D, Fahn S. Pharmacologic evaluation of dompaminergic receptor blockade by metoclopramide. Clin Neuropharm 1986; 9: 71–8
   Google Scholar
• Stumpe K O, Kollock R, Higuchi M, Kruck F, Vetter H. Hyperprolactinemia and antihypertensive effect of bromocriptine in essential hypertension: identification of abnormal central dopamine control. Lancet 1977; 2: 211–4
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Flaaten B, Eide I, Helgeland A, Leren P, Fonstelien E. Decreased peripheral dopaminergic activity in essential hypertension?. Scand J Clin Lab Invest 1983; 43: 15–20
   PubMed Web of Science ®Google Scholar
• Os I, Kjeldsen S E, Westheim A, Aakesson I, Norman N, Enger E, Hjermann I, Eide I. Decreased central dopaminergic activity in essential hypertension. J Hypertens 1987; 5: 191–7
   PubMed Web of Science ®Google Scholar
• Goldberg L I. Dopamine receptors and hypertension. Physiologic and pharmacologic implications. Am J Med 1984; 77: 37–44
   PubMed Web of Science ®Google Scholar
• Os I, Kjeldsen S E, Westheim A, Lande K, Norman N, Hjermann I, Eide I. Endocrine and haemodynamic responses to graded dopamine infusion in essential hypertension. Scand J Clin Lab Invest 1987; 47: 371–7
   PubMed Web of Science ®Google Scholar
• Peuler J D, Johnson G A. Simultaneous single isotope radio-enzyme assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 1977; 21: 625–36
   PubMed Web of Science ®Google Scholar
• Kjeldsen S E, Flaaten B, Eide I, Helgeland A, Leren P. Evidence of increased peripheral catecholamine release in patients with longstanding, untreated essential hypertension. Scand J Clin Lab Invest 1982; 42: 217–23
   PubMed Web of Science ®Google Scholar
• Rutlin E, Haug E, Torjesen P A. Serum thyro-trophin, prolactin and growth hormone, response to TRH during oestrogen treatment. Acta Endocrinol 1977; 84: 23–35
   PubMedGoogle Scholar
• Brown B W, Hollander M. Statistics. A biomedical introduction. John Wiley, New York 1977; 310–39
   Google Scholar
• Conover W J. Practical Nonparametric Statistics, 2nd ed. John Wiley, New York 1980; 299–300
   Google Scholar
• MacLeod R M. Regulation of prolactin secretion. Frontiers in neuroendocrinology 1976; 4: 169–95
   Google Scholar
• Kaplan K L, Owen J. Plasma levels of platelet secretory proteins. CRC Critical Reviews in Oncology/Hematology 1986; 5: 235–55
   PubMed Web of Science ®Google Scholar
• Bugiardini R, Chierchia S, Crea F, Gallino A, Wild S, Roskovec A, Lenzi S, Maseri A. Evaluation of the effects of catheter sampling for the study of platelet behavior in pulmonary and coronary circulation. Am Heart J 1984; 108: 255–60
   Google Scholar
• Karpatkin S. Heterogenity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978; 51(2)307–16
   PubMed Web of Science ®Google Scholar
• Eldor A, Avitzour M, Or R, Hanna R, Penchas S. Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J 1982; 285: 397–400
   PubMed Web of Science ®Google Scholar
• Thompson C B, Eaton K A, Princiotta S M, Rushin C A, Vareri C R. Size dependent platelet sub-populations: Relationship of platelet volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982; 50: 509–19
   PubMed Web of Science ®Google Scholar
• Bruschi G, Minari M, Bruschi M E, Tacinelli L, Milani B, Cavatorta A, Borghetti A. Similarities of essential and spontaneous hypertension. Volume and number of blood cells. Hypertension 1986; 8: 983–9
   PubMed Web of Science ®Google Scholar
• Martin J F, Plumb J, Kilbey R S, Kishk Y T. Changes in volume and density of platelets in myocardial infarction. Br Med J 1983; 287: 456–9
   PubMed Web of Science ®Google Scholar
• Cameron H A, Phillips R, Ibbotson R M, Carson P HM. Platelet size in myocardial infarction. Br Med J 1983; 287: 449–51
   PubMed Web of Science ®Google Scholar
• Giles C. The platelet count and mean platelet volume. Br J Haematol 1981; 48: 31–7
   PubMed Web of Science ®Google Scholar
• Trowbridge E A, Reardon D M, Hutchinson D, Pickering C. The routine measurement of platelet volume: a comparison of light-scattering and aperture-impedance technologies. Clin Phys Physiol Meas 1985; 6: 221–38
   PubMedGoogle Scholar
• Aster R H. Pooling of platelets in the spleen: Role in the pathogenesis of ‘hypersplenic’ thrombocytopenia. J Clin Invest 1966; 45: 645–57
   PubMed Web of Science ®Google Scholar
• Thompson C B, Jokubowski J A. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1988; 72: 1–8
   PubMed Web of Science ®Google Scholar
• De Keyser J, De Waele M, Convents A, Ebinger G, Vanquelin G. Identification of Drlike receptors on the human blood platelets. Life Scien 1988; 42: 1797–1806
   PubMed Web of Science ®Google Scholar
• Altman D G. Statistics and ethics in medical research: 3 How Large a sample?. Br Med J 1980; 280: 1336–8
   Google Scholar